Icosavax Inc (DELISTED) (ICVX:DL)
15.31
0.00 (0.00%)
USD |
NASDAQ |
Feb 29, 16:00
Icosavax Research and Development Expense (Annual): 65.41M for Dec. 31, 2022
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2022 | 65.41M |
| December 31, 2021 | 38.78M |
| Date | Value |
|---|---|
| December 31, 2020 | 17.67M |
| December 31, 2019 | 4.157M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
4.157M
Minimum
2019
65.41M
Maximum
2022
31.50M
Average
28.22M
Median
Research and Development Expense (Annual) Benchmarks
| Karuna Therapeutics Inc (DELISTED) | 364.10M |
| Immunogen Inc (DELISTED) | 213.37M |
| AbbVie Inc | 7.675B |
| Assure Holdings Corp | -- |
| Harpoon Therapeutics Inc (DELISTED) | 81.39M |